A dimorphic blast population demonstrates Philadelphia-positive mixed phenotype acute leukaemia

Pathology. 2014 Apr;46(3):244-6. doi: 10.1097/PAT.0000000000000086.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Benzamides / therapeutic use*
  • Biopsy, Needle
  • Bone Marrow / pathology
  • Diagnosis, Differential
  • Female
  • Flow Cytometry
  • Granulocyte Precursor Cells
  • Humans
  • Imatinib Mesylate
  • In Situ Hybridization, Fluorescence
  • Induction Chemotherapy
  • Karyotyping
  • Leukemia, Biphenotypic, Acute / diagnosis*
  • Leukemia, Biphenotypic, Acute / drug therapy
  • Leukemia, Biphenotypic, Acute / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Phenotype
  • Philadelphia Chromosome
  • Piperazines / therapeutic use*
  • Prognosis
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate